ANI Pharmaceuticals Non-GAAP EPS of $2.21 beats by $0.17, revenue of $266.04M beats by $5.91M (ANIP:NASDAQ)
· seekingalpha.com
ANI Pharmaceuticals (ANIP) Q2 earnings beat: EPS $2.21, revenue up 26% to $266M, Cortrophin Gel +44%.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...